Your Article Summary
See Latest ArticlesIloperidone (Fanapt): Psychotropic agent approved for the acute treatment of schizophrenia
Formulary , 06/08/09
The mechanism of action of iloperidone, a psychotropic agent, is unknown, but researchers have proposed that the agent's efficacy is mediated through antagonism of dopamine type 2 (D2) and serotonin type 2 (5-HT2). This agent was approved on May 2009, for the acute treatment of adult patients with schizophrenia.
Today in Drug/Product Approvals...keeping you current
Receive free subspecialty "5-minute updates" via email
Novartis receives approval in the European Union for Onbrez Breezhaler, a new once-daily bronchodilator for patients with COPD
Novartis, 12/04/09
Teva Announces The Submission Of A Biologics License Application (BLA) For XM02 For The Treatment Of Chemotherapy-Induced Neutropenia
Teva Pharmaceutical Industries, 12/02/09
Bayer's Betaferon approved in China for Treatment of Multiple Sclerosis
BayNews International, 12/02/09